Long‐term quality of life in patients with bladder cancer following radical cystectomy
Open Access
- 1 December 2024
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 135 (4) , 675-683
Abstract
Objectives: To investigate changes in quality of life (QoL) up to 8 years after radical cystectomy (RC) and compare QoL after RC with a gender‐ and age‐matched Dutch normative population. Furthermore, we aimed to identify patient characteristics associated with QoL and QoL trajectories after RC. Patients and Methods: Patients with bladder cancer were invited to complete QoL questionnaires at 3‐month intervals in the first year and yearly thereafter. Follow‐up data were available for a maximum of 8 years. We used linear mixed‐effect models to investigate changes in QoL subscales (physical functioning [PF], emotional functioning [EF], and QoL summary score [QoL‐sum]) over time, and to identify potential demographic and clinical correlates of QoL and QoL trajectories (i.e., interaction with time). Results: Data from 278 patients was included. Post‐RC EF scores increased from 83.7 (95% confidence interval [CI] 81.7–85.6) to levels comparable to the normative population (90.1) 8 years after RC. PF (post‐RC: 82.4, 95% CI 78.5–86.3) and QoL‐sum (post‐RC: 88.2, 95% CI 85.2–91.2) remained lower compared to the normative population (88.9 and 91.4, respectively) 8 years after RC. Compared to patients with an American Society of Anesthesiologists (ASA) score of 1 at diagnosis, those with ASA score 2 or ASA score 3 had significant lower post‐RC PF (mean difference (MD) = −8 and −22, respectively; P < 0.001), EF (MD = −1 and −11; P = 0.5 and P < 0.01) and QoL‐sum (MD = −2 and −9; P = 0.2 and P < 0.01). In addition, patients with a higher ASA score had a worse QoL‐sum trajectory ( P interaction = 0.01). Older patients had a worse PF trajectory ( P interaction < 0.01) but higher post‐RC EF ( P < 0.01). Conclusions: Directly after RC, patients have lower PF, EF and QoL‐sum, compared to a normative population. Notably, EF recovers to normative levels over a period of 8 years after RC. Clinicians are encouraged to administer supportive care interventions to enhance the QoL for patients undergoing RC, especially targeting older patients and those with higher ASA scores.Keywords
This publication has 27 references indexed in Scilit:
- Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy: a double-blinded, randomised feasibility trialWorld Journal of Urology, 2022
- Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder CancerJAMA, 2022
- Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomised Controlled TrialEuropean Urology Focus, 2022
- Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: A longitudinal studyPsycho-Oncology, 2021
- Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella reviewQuality of Life Research, 2020
- Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysisQuality of Life Research, 2018
- Health related quality of life (HRQoL) after cystectomy: Comparison between orthotopic neobladder and ileal conduit diversionEuropean Journal of Surgical Oncology, 2015
- Quality of life in patients with muscle invasive and non-muscle invasive bladder cancerSupportive Care in Cancer, 2012
- Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30European Journal of Cancer, 2012
- Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch populationEuropean Journal of Cancer, 2011